journal article·2019-05-08

Highly Oxidized Graphene Quantum Dots from Coal as Efficient Antioxidants

Lizanne Nilewski, Kimberly Mendoza, Almaz S. Jalilov, Vladimir Berka, Gang Wu, William K. A. Sikkema, Andrew Metzger, Ruquan Ye, Rui Zhang, Duy Xuan Luong, Tuo Wang, Emily McHugh, Paul J. Derry, Errol Loïc Samuel, Thomas A. Kent, Ah-Lim Tsai, James M. Tour

ACS Applied Materials & Interfaces· Volume 11· Issue 18
Publisher page

Abstract

Graphene quantum dots (GQDs) have recently been employed in various fields including medicine as antioxidants, primarily because of favorable biocompatibility in comparison to common inorganic quantum dots, although the structural features that lead to the biological activities of GQDs are poorly understood. Here, we report that coal-derived GQDs and their poly(ethylene glycol)-functionalized derivatives serve as efficient antioxidants, and we evaluate their electrochemical, chemical, and in vitro biological activities.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Graphene and Nanomaterials Applications · Electrochemical sensors and biosensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, United States

Hematology, Internal Medicine. University of Texas McGovern Medical School—Houston, Houston, Texas 77030, United States

Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas 77030, United States

Stanley H. Appel Department of Neurology and Research Institute, Houston Methodist Hospital, Houston, Texas 77030, United States

Funding

John S. Dunn Foundation · U.S. Department of Defense · National Institutes of Health · Welch Foundation · National Institute of Neurological Disorders and Stroke · Alliance for Nanohealth

References (31)

Show source-provided references
1. 10.1016/j.tibtech.2014.08.00510.1016/j.tibtech.2014.08.005 ↗
2. 10.1016/j.biocel.2006.07.00110.1016/j.biocel.2006.07.001 ↗
3. 10.1021/acsanm.8b0040410.1021/acsanm.8b00404 ↗
4. 10.1021/acsnano.6b0406110.1021/acsnano.6b04061 ↗
5. 10.1016/j.carbon.2017.01.09010.1016/j.carbon.2017.01.090 ↗
6. 10.1016/j.carbon.2016.05.07010.1016/j.carbon.2016.05.070 ↗
7. 10.1021/acsami.5b0322810.1021/acsami.5b03228 ↗
8. 10.1021/acsnano.6b0821110.1021/acsnano.6b08211 ↗
9. 10.1021/jp305302y10.1021/jp305302y ↗
10. 10.1089/neu.2011.230110.1089/neu.2011.2301 ↗
11. 10.1021/nn204867910.1021/nn2048679 ↗
12. 10.1021/nn202129310.1021/nn2021293 ↗
13. 10.1021/ja805721p10.1021/ja805721p ↗
14. 10.1038/ncomms394310.1038/ncomms3943 ↗
15. 10.1021/acsami.5b0141910.1021/acsami.5b01419 ↗
16. 10.3389/fimmu.2017.0067310.3389/fimmu.2017.00673 ↗
17. 10.1021/acsami.6b0350210.1021/acsami.6b03502 ↗
18. 10.3390/molecules2204057710.3390/molecules22040577 ↗
19. 10.1016/s0169-409x(03)00108-x10.1016/s0169-409x(03)00108-x ↗
20. 10.1016/j.xphs.2015.11.01510.1016/j.xphs.2015.11.015 ↗
21. 10.1016/j.progpolymsci.2012.07.00610.1016/j.progpolymsci.2012.07.006 ↗
22. 10.1073/pnas.141704711210.1073/pnas.1417047112 ↗
23. 10.1088/0953-8984/27/8/08300210.1088/0953-8984/27/8/083002 ↗
24. 10.1021/acsnano.8b0475810.1021/acsnano.8b04758 ↗
25. 10.1021/nn500606a10.1021/nn500606a ↗
26. Fee J. A. · J. Biol. Chem. · 1986 · 261 · 1300010.1016/S0021-9258(18)69261-0 ↗
27. 10.1016/j.abb.2006.09.03110.1016/j.abb.2006.09.031 ↗
28. 10.1016/j.freeradbiomed.2014.03.01910.1016/j.freeradbiomed.2014.03.019 ↗
29. Finkelstein E. · Mol. Pharmacol. · 1982 · 21 · 262
30. 10.3389/fneur.2018.0019910.3389/fneur.2018.00199 ↗
31. 10.1021/acschemneuro.7b0013810.1021/acschemneuro.7b00138 ↗